Investor Update
Basel 18 September 2009
Antineoplastic Agent / Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor, Tarceva
Application for Approval of Additional Indication of Pancreatic Cancer
Dear Investor,
Please find enclosed a press release by Chugai: